Literature DB >> 12773465

Cryo-thawed embryos obtained from conception cycles have double the implantation and pregnancy potential of those from unsuccessful cycles.

T El-Toukhy1, Y Khalaf, K Al-Darazi, F O'Mahony, E Wharf, A Taylor, P Braude.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the influence of fresh IVF/ICSI cycle outcome on the prognosis of the related frozen embryo replacement (FER) cycle.
METHODS: 459 FER cycles, involving 2049 cleavage stage embryos with no or up to 10% fragmentation, were performed for which the outcome of the fresh cycle was recorded. The cycles were divided into two groups; group A included cycles in which cryopreserved embryos were obtained from fresh cycles in which conception occurred. Group B were cycles in which cryopreserved embryos originated from unsuccessful fresh cycles.
RESULTS: Groups A and B were comparable with respect to mean (+/- SD) age at cryopreservation (33 +/- 3.9 versus 33.2 +/- 4 years, P = not significant), mean number of oocytes retrieved and fertilized normally in the fresh cycle (11 +/- 5.2 versus 11.2 +/- 4.8, P = not significant) and mean age at the cryo-thawed transfer (34.5 +/- 4.2 versus 33.9 +/- 4 years, P = not significant). No significant difference was found between the two groups with regard to mean number of embryos cryopreserved (6.5 +/- 3.9 versus 6.2 +/- 3.6) and subsequently thawed (4.5 +/- 2.5 versus 4.5 +/- 1.8) per cycle and number of cryo-thawed embryos transferred per cycle (2.0 +/- 0.7 versus 2.1 +/- 0.8). However, the implantation rate per transferred embryo in group A was double that in group B (23 versus 11.2%, P < 0.0001). Moreover, the clinical pregnancy and ongoing pregnancy rates per cycle were significantly higher in group A compared with group B (34.8 and 27.3% versus 15.6 and 13.1%, P < 0.0001 and P = 0.0003 respectively). The difference in FER cycle outcome could not be explained by confounding variables.
CONCLUSIONS: After thawing, cryopreserved embryos originating from conception IVF/ICSI cycles achieve double the implantation and pregnancy rates of those obtained from unsuccessful cycles.

Entities:  

Mesh:

Year:  2003        PMID: 12773465     DOI: 10.1093/humrep/deg235

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Frozen-thawed embryo transfer cycles: clinical outcomes of single and double blastocyst transfers.

Authors:  Inna Berin; Sarah T McLellan; Eric A Macklin; Thomas L Toth; Diane L Wright
Journal:  J Assist Reprod Genet       Date:  2011-03-04       Impact factor: 3.412

2.  Frozen-thawed embryo transfer cycles in China: clinical outcomes of two and three multicellular embryos transfers.

Authors:  Yijuan Sun; Yun Feng; Aijun Zhang; Xiaowei Lu; Zhihong Niu; Ruihuan Gu
Journal:  J Assist Reprod Genet       Date:  2012-03-15       Impact factor: 3.412

3.  Serum progesterone on the day of human chorionic gonadotropin administration predicts clinical pregnancy of sibling frozen embryos.

Authors:  Alex J Polotsky; Jennifer L Daif; Sangita Jindal; Harry J Lieman; Nanette Santoro; Lubna Pal
Journal:  Fertil Steril       Date:  2008-10-11       Impact factor: 7.329

4.  Endometrial thickness as a predictor of the reproductive outcomes in fresh and frozen embryo transfer cycles: A retrospective cohort study of 1512 IVF cycles with morphologically good-quality blastocyst.

Authors:  Tao Zhang; Zhou Li; Xinling Ren; Bo Huang; Guijin Zhu; Wei Yang; Lei Jin
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

5.  Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial. (ANTARCTICA trial).

Authors:  Eva R Groenewoud; Nick S Macklon; Ben J Cohlen
Journal:  BMC Womens Health       Date:  2012-09-05       Impact factor: 2.809

6.  Dynamic blastomere behaviour reflects human embryo ploidy by the four-cell stage.

Authors:  Shawn L Chavez; Kevin E Loewke; Jinnuo Han; Farshid Moussavi; Pere Colls; Santiago Munne; Barry Behr; Renee A Reijo Pera
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

7.  Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden.

Authors:  Jaro Wex; Ahmed M Abou-Setta
Journal:  Clinicoecon Outcomes Res       Date:  2013-08-09

8.  Comparison of epigenetic mediator expression and function in mouse and human embryonic blastomeres.

Authors:  Shawn L Chavez; Sohyun L McElroy; Nancy L Bossert; Christopher J De Jonge; Maria Vera Rodriguez; Denise E Leong; Barry Behr; Lynn M Westphal; Renee A Reijo Pera
Journal:  Hum Mol Genet       Date:  2014-05-12       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.